Trials / Completed
CompletedNCT01631071
Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains
Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2012/2013-Season Virosomal Subunit Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Crucell Holland BV · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study is to assess whether the virosomal influenza vaccine for season 2012/2013 fulfills the EMA requirements for re-registration of influenza vaccines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Virosomal influenza vaccine | Intramuscular administration (M. deltoideus) of a single dose of 0.5 mL virosomal influenza vaccine |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-06-28
- Last updated
- 2013-12-20
- Results posted
- 2013-12-20
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01631071. Inclusion in this directory is not an endorsement.